Pharmadule Morimatsu Reinforces Asian Presence at CHINA-PHARM 2013

Nacka, Stockholm: – Swedish-based designer and builder of modular production facilities for the pharma and biopharma industries, Pharmadule Morimatsu AB (Pharmadule) will emphasize its new profile within the rapidly expanding Asian life sciences market with a prominent presence and exhibition at the forthcoming the 18th China International Pharmaceutical Industry Exhibition, CHINA-PHARM 2013.

The exhibition, which has become the premier event for the Asian pharma sector, is being held from October 29 to November 1 at Shanghai’s New International Expo Centre (SNIEC).

Pharmadule Morimatsu is sending a multi-disciplinary team to this premier Asian networking and partnering event.

Exciting Developments
“This will be our fourth appearance at CHINA-PHARM, which has become the major trade show for Pharmadule Morimatsu in the Chinese and Asian market,” said Daniel Ding, Chief Executive Officer.

Pharmadule’s Regulatory Affairs Director, Magnus Jansson, will host a presentation at SNIEC on using Quality Risk Management to provide a scientific rationale for Process Validation, emphasizing the company’s in-depth expertise in pharma and biopharma process and compliance requirements.

Mr. Ding also revealed that Pharmadule would join fellow Swedish-based company, Alfa Laval, the heat transfer, separation and fluid-handling specialists, to co-host a pre-exhibition BioPharm 2013 seminar on October 28, at the Renaissance Shanghai Pudong Hotel.

“We aim to strengthen our position on the Chinese market, increase brand awareness of Pharmadule and knowledge of our products and services,” said Mr. Ding.

Modular Production Solutions
Pharmadule Morimatsu will be present at Stand 5615 in the SNIEC Centre, where its team will be able to provide details of its offerings, including turnkey design and construction services, modular off-site production solutions, commissioning and qualification expertise, GMP consultancy and extended after-sales services.

The company will also be using the exhibition’s networking opportunities to identify forthcoming project leads and partners.

“We aim to demonstrate how our leading-edge modular production models and all-enveloping services that extends from concept to delivery and beyond remove risk and uncertainty for the client”, said Mr. Ding.

“It’s also important for potential partners to understand how our industry-focused expertise adds value to every stage of the process. For example, we will be showing how we can deploy expertise within commissioning and qualification, by performing IQ and OQ according to current GMP standards and adopting the ‘Lifecycle’ structure from the FDA Process Validation Guide.”

About Pharmadule Morimatsu
Pharmadule Morimatsu designs and builds turnkey production facilities for the pharma and biopharma Industries. Pharmadule services extend from conceptual design to IQ/OQ completion.

The company was founded in 1986, since when it has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca.

Over more than a quarter of a century, the company has forged The Pharmadule Way as a way of offering unique value and reassurance to customers, as its driving force. This includes off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality.

Pharmadule’s replicable and well-proven delivery model is designed to ensure the success of each and every project, from meeting market demand to maximizing Return on Investment. The company uses an off-site modular build concept that helps ensure consistent delivery of high quality facilities regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.

Pharmadule Morimatsu offers a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance and Validation Management and comprehensive After Sales Support.

About CHINA-PHARM 2013
The China International Pharmaceutical Industry Exhibition & China International Pharmaceutical Industry Forum (CHINA-PHARM for short) has now become one of the foremost life sciences events in Asia with significant influence on the international pharmaceutical field.

The 18th China International Pharmaceutical Industry Exhibition is returning to Shanghai, having been staged in Beijing in 2012.

Covering a space of around 25,000 sqm, CHINA-PHARM 2013 is expected to attract over 400 leading Chinese and international brands as well as over 20,000 trade visitors, of whom some 3,000 will come from EMEA and the Americas.

CHINA-PHARM is hosted by the China Center for Pharmaceutical International Exchange (CCPIE), in partnership with Messe Düsseldorf China Ltd. (MDC). The latter was founded in 1999 as a joint venture between Messe Düsseldorf GmbH and World-Fair Consultants Ltd. to bring long-established German events to China.

Contact:
Pharmadule Morimatsu AB
Maria Rosen, Director of Marketing
Tel: +46 (0)8 587 42 000
Email: [email protected]

For more information about Pharmadule Morimatsu reinforces Asian presence at CHINA-PHARM 2013, please contact Pharmadule Morimatsu directly.